Projects & Funding

Development of recombinant antibodies with high potency and neutralization for treatment and prevention of SARSCoV-2 infection

Reference: PGG/013823/2021
Funding Agency: Gilead GÉNESE Program
PI: Frederico Aires da Silva (FMV)
Period: 2021-2024
Grant: 39.000€

Development of potent and broadly neutralizing antibodies fragments for COVID-19 derived from domestic cats naturally infected with SARS-CoV-2

Reference: PTDC/CVT-CVT/0149/2021
Funding Agency: Fundação para a Ciência e a Tecnologia (FCT)
PI: Frederico Aires da Silva (FMV)
Period: 2021-2025
Grant: 249.328,24 €

Vector B2B – Drug Developing – Association for Research in Biotechnology

Reference: Vector B2B
Funding Agency: Fundação para a Ciência e a Tecnologia (FCT)
Period: 2019-
Consortium Partners: FMV, FM, FF, CNC.IBILI, Medinfar, Bevag and TechnoPhage

Development of a novel class of antibody-drug conjugates molecules for cancer treatment

Reference: PTDC/BTM-SAL/32085/2017
Funding Agency: Fundação para a Ciência e a Tecnologia (FCT)
PI: Frederico Aires da Silva (FMV)
Period: 2018-2021
Grant: 239.000€

Peptides for blood brain barrier transmigration and drug delivery

Reference: (PTDC/BBBNAN/1578/2014)
Funding Agency: Fundação para a Ciência e a Tecnologia (FCT)
PI: Vera Neves (IMM)
Period: 2016-2019
Grant: 190.090,00€

LYMPHOTARGET – Development of immunoliposomes for specific targeting of non-Hodgkin’s lymphoma treatment

Reference: PGG/050/2019
Funding Agency: Gilead GÉNESE Program
PI: Joana Dias (FMV)
Period: 2020-2022
Grant: 39.700€

Overcoming the Brain Drug Delivery Bottleneck: Development of single domain antibodies for brain targeting and drug delivery across the Blood-Brain Barrier

Reference: PTDC/BBBBIO/0508/2014
Funding Agency: Fundação para a Ciência e a Tecnologia (FCT)
PI: Frederico Aires da Silva (FMV)
Period: 2016-2019
Grant: 192.320,00€

Alzheimer3D: Trifunctional Conjugates for the Selective Drug Delivery in Alzheimer’s Disease

Reference: PTDC/BBBNAN/1578/2014
Funding Agency: Fundação para a Ciência e a Tecnologia (FCT)
PI: Rudi Oliveira (FF)
Period: 2016-2019
Grant: 198.364,00€

Development of anti-gp120/gp41 bispecific antibodies for treatment of HIV infection

Reference: PGG/015/2016
Funding Agency: Gilead GÉNESE Program
PI: Frederico Aires da Silva (FMV)
Period: 2017-2019
Grant: 21.000€

Exploratory FCT Investigator Starting Grant Program

Reference: IF/01010/2013/CP1183/CT0001
Funding Agency: Fundação para a Ciência e a Tecnologia (FCT)
PI: Frederico Aires da Silva (FMV)
Period: 2013-2018
Grant: 50.000 €